APWA
TEVA icon

Atlas Private Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Atlas Private Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-355
Closed -$3K – 630
2021
Q3 		$3K Hold
355
– – ﹤0.01% 640
2021
Q2 		$4K Hold
355
– – ﹤0.01% 609
2021
Q1 		$4K Sell
355
-200
-36% -$2.29K ﹤0.01% 660
2020
Q4 		$5K Sell
555
-200
-26% -$1.92K ﹤0.01% 538
2020
Q3 		$7K Sell
755
-200
-21% -$2.12K 0.01% 441
2020
Q2 		$12K Buy
+955
New +$10.8K 0.01% 386

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Atlas Private Wealth Advisors's TEVA Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 355 shares — an estimated $3K sold.

Atlas Private Wealth Advisors first reported a position in TEVA in Q2 2020 and held it in 6 quarters. The position peaked at $12K in Q2 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Atlas Private Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Atlas Private Wealth Advisors sold 355 Teva Pharmaceuticals shares in Q4 2021, an estimated $3K.
  • Atlas Private Wealth Advisors first reported a position in Teva Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Atlas Private Wealth Advisors's Teva Pharmaceuticals position peaked at $12K in Q2 2020.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.